Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0120USD
−510.75 KUSD
3.56 MUSD
44.67 M
About MUSTGROW BIOLOGICS CORP
Sector
CEO
Corey J. Giasson
Headquarters
Saskatoon
Website
Founded
2014
FIGI
BBG00Q5MJQY3
MustGrow Biologics Corp. engages in the development and commercialization of natural biopesticide products from mustard seed. It offers preplant soil biofumigant, bioherbicide, and postharvest food preservation. The company was founded on December 2, 2014 and is headquartered in Saskatoon, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MGROF is 0.7800 USD — it has increased by 0.74% in the past 24 hours. Watch MustGrow Biologics Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange MustGrow Biologics Corporation stocks are traded under the ticker MGROF.
MustGrow Biologics Corporation is going to release the next earnings report on May 23, 2024. Keep track of upcoming events with our Earnings Calendar.
MGROF stock is 6.52% volatile and has beta coefficient of 1.61. Track MustGrow Biologics Corporation stock price on the chart and check out the list of the most volatile stocks — is MustGrow Biologics Corporation there?
MGROF earnings for the last quarter are 0.05 USD per share, whereas the estimation was −0.02 USD resulting in a 450.00% surprise. The estimated earnings for the next quarter are −0.01 USD per share. See more details about MustGrow Biologics Corporation earnings.
MustGrow Biologics Corporation revenue for the last quarter amounts to 3.55 M USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 0 USD.
Yes, you can track MustGrow Biologics Corporation financials in yearly and quarterly reports right on TradingView.
MGROF stock has fallen by 0.34% compared to the previous week, the month change is a 8.02% fall, over the last year MustGrow Biologics Corporation has showed a 56.91% decrease.
MGROF net income for the last quarter is 2.59 M USD, while the quarter before that showed −1.37 M USD of net income which accounts for 289.07% change. Track more MustGrow Biologics Corporation financial stats to get the full picture.
Today MustGrow Biologics Corporation has the market capitalization of 37.21 M, it has decreased by 3.96% over the last week.
No, MGROF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MGROF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MustGrow Biologics Corporation stock right from TradingView charts — choose your broker and connect to your account.
MGROF reached its all-time high on Oct 26, 2021 with the price of 4.5108 USD, and its all-time low was 0.0100 USD and was reached on Jan 14, 2020. View more price dynamics on MGROF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MustGrow Biologics Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MustGrow Biologics Corporation stock shows the sell signal. See more of MustGrow Biologics Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MustGrow Biologics Corporation EBITDA is −607.36 K USD, and current EBITDA margin is −17.08%. See more stats in MustGrow Biologics Corporation financial statements.